Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA.

Source:http://linkedlifedata.com/resource/pubmed/id/17686636

Download in:

View as

General Info

PMID
17686636